NCT02198547

Magnesium as Adjuvant for Sciatic Block

Evaluation of Magnesium as Adjuvant to Ropivacaine for Sciatic Block at Popliteal Level.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Campus Bio-Medico University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to evaluate if Magnesium added to ropivacaine can reduce onset time and can enhance offset time.

Detailed description

Patients are randomly divided into two groups: group "M" (Ropivacaina 7,5 mg/ml with Mg 4 mg/Kg)and group"C" (without Mg). Standard monitoring is applied to each patient in perioperative period. An indipendent observer collect data: time to perform block, sensitivity onset,motor onset, pain during surgery and complication. In the post-operative period till 24 hours for each patient is evaluated off-set time, pain and analgesic consumption.

Conditions

• Hallux Valgus

Interventions

Type	Name	Description
DRUG	Magnesium Sulfate	Mg used with ropivacaine for sciatic nerve blick
DRUG	Ropivacaine	Ropivacaine 7,5 mg/ml used for sciatic nerve block

Timeline

• Start date: 2014-03-01
• Primary completion: 2020-07-01
• Completion: 2022-09-01
• First posted: 2014-07-23
• Last updated: 2024-08-26

Locations

1 site across 1 country: Italy